The store will not work correctly when cookies are disabled.
(S)-2-(2,6-dichlorophenyl)-1-(1-methyl-3,4-dihydroisoquinolin-2(1H)-yl)ethanone
ID: ALA4519818
PubChem CID: 132016545
Max Phase: Preclinical
Molecular Formula: C18H17Cl2NO
Molecular Weight: 334.25
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: C[C@H]1c2ccccc2CCN1C(=O)Cc1c(Cl)cccc1Cl
Standard InChI: InChI=1S/C18H17Cl2NO/c1-12-14-6-3-2-5-13(14)9-10-21(12)18(22)11-15-16(19)7-4-8-17(15)20/h2-8,12H,9-11H2,1H3/t12-/m0/s1
Standard InChI Key: SUTPENAAFLOLOK-LBPRGKRZSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
38.1507 -12.3445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1495 -13.1640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8576 -13.5730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8558 -11.9356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5644 -12.3409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5633 -13.1615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2695 -13.5706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9813 -13.1635 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.9825 -12.3429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2718 -11.9293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2672 -14.3878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6879 -13.5741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6856 -14.3913 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.3967 -13.1675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1033 -13.5781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.0956 -14.3927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.8014 -14.8032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.5112 -14.3965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.5108 -13.5751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.8045 -13.1683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.3853 -14.7968 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
43.8020 -12.3511 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
7 11 1 1
8 12 1 0
12 13 2 0
12 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
16 21 1 0
20 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 334.25 | Molecular Weight (Monoisotopic): 333.0687 | AlogP: 4.68 | #Rotatable Bonds: 2 |
Polar Surface Area: 20.31 | Molecular Species: NEUTRAL | HBA: 1 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.64 | CX LogD: 4.64 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.78 | Np Likeness Score: -0.93 |
References
1. Hall A, Provins L, Valade A.. (2019) Novel Strategies To Activate the Dopamine D1 Receptor: Recent Advances in Orthosteric Agonism and Positive Allosteric Modulation., 62 (1): [PMID:30525590] [10.1021/acs.jmedchem.8b01767] |